Saturday 17 October 2026
Export INBS’s income statement to Excel — free account
Intelligent Bio Solutions Inc.
INBS Healthcare Medical Devices
Intelligent Bio Solutions Inc.’s revenue for fiscal 2026 (year ended June 2026) was $4.2 million, up 38.1% from fiscal 2025. In the quarter to June 2026, revenue grew 51.1%, EPS grew 78.1% and free cash flow fell 31.6%, each against the same quarter a year earlier.
1.50
0.06
+4.17%
Follow INBS
Intelligent Bio Solutions Inc. (INBS) P/E ratio
Intelligent Bio Solutions Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.4× (February 2025) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 21 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.4×
Ten-year median
0.0×
Current reading's percentile
87
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| VNRX VolitionRX Limited compare | n/m |
| TBIO Telesis Bio Inc. compare | n/m |
| CODX Co-Diagnostics, Inc. compare | n/m |
| AMIX Autonomix Medical, Inc. compare | n/m |
| INBS Intelligent Bio Solutions Inc. | n/m |
| TRIB Trinity Biotech PLC compare | n/m |
| VVOS Vivos Therapeutics, Inc. compare | n/m |
| NVNO enVVeno Medical Corporation compare | n/m |
| WOK WORK Medical Technology Group LTD compare | — |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)